Biogen (BIIB) Assets Average (2009 - 2026)

Biogen's Assets Average history runs 18 years deep, the most recent figure standing at $29.5 billion for Q1 2026.

• In Q1 2026, Assets Average rose 5.06% year-over-year to $29.5 billion; the TTM figure through Mar 2026 stood at $29.5 billion (up 5.06% YoY), while the FY2025 annual figure was $28.7 billion, up 4.73% from the prior year.
• Assets Average was $29.5 billion for Q1 2026 at Biogen, roughly flat from $29.3 billion in the prior quarter.
• In the past five years, Assets Average ranged from a high of $29.5 billion in Q1 2026 to a low of $23.7 billion in Q1 2022.
• Historically, Assets Average has averaged $26.7 billion across 5 years, with a median of $26.7 billion in 2024.
• The sharpest annual moves came in 2022 and 2023: Assets Average declined 2.03% in 2022, then rose 11.39% in 2023.
• A 5-year view of Assets Average shows it stood at $24.7 billion in 2022, then climbed by 11.39% to $27.5 billion in 2023, then gained by 2.41% to $28.2 billion in 2024, then advanced by 4.05% to $29.3 billion in 2025, then gained by 0.47% to $29.5 billion in 2026.
• The last three Assets Average figures came in at $29.5 billion (Q1 2026), $29.3 billion (Q4 2025), and $28.8 billion (Q3 2025), per Business Quant data.